RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancerMelinda Magna, Barry I. Hudson, Masaru Takabatake et al.|npj Breast Cancer|2023Cited by 42
Abstract P4-08-10: Azeliragon (TTP488), an orally- available small molecule RAGE inhibitor, reduces metastasis in preclinical mouse models of breast cancerMelinda Magna, Barry I. Hudson, Alec McIntosh et al.|Cancer Research|2023Cited by 0